# Alexo Therapeutics Ltd — Form D

Alexo Therapeutics Ltd of DUBLIN 2, L2, a company, filed a Form D exempt-offering notice with the SEC on 2015-05-21. The offering totals $36.0M, of which $18.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2015-05-21
- Form: D
- Accession: 0001642930-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $36.0M
- Amount sold: $18.0M
- Remaining: $18.0M
- Minimum investment: $38K
- Investors: 14
- Date of first sale: 2015-05-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-240360

## Issuer

- Name: Alexo Therapeutics Ltd
- CIK: 0001642930
- Entity type: Other
- Jurisdiction: IRELAND
- Incorporated: 2015
- Address: C/O BRADWELL LIMITED, DUBLIN 2, L2, 000000
- Phone: 35-3-1-618-000

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Corey Goodman | Director | Cambridge, MA |
| Jason Lettman | Director | Minneapolis, MN |
| Jaume Pons | Director | Burlingame, CA |
| n/a Bradwell Limited | Executive Officer | Dublin 2, L2 |

## More

- [CIK 1642930 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1642930&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001642930-15-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.